
Danish drug maker Novo Nordisk has said it will offer a generic version of NovoLog (insulin aspart) at a price …

Novo Nordisk has submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. If successful, the Danish …

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

